Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021

Juliane Ankert; Stefan Hagel; Claudia Schwarz; Kaijie Pan; Liz Wang; Christof von Eiff; Bradford D Gessner; Christian Theilacker; Mathias W Pletz

doi:10.1183/23120541.00703-2022

Streptococcus pneumoniae re-emerges as a cause of community-acquired pneumonia, including frequent co-infection with SARS-CoV-2, in Germany, 2021

ERJ Open Res. 2023 May 30;9(3):00703-2022. doi: 10.1183/23120541.00703-2022. eCollection 2023 May.

Authors

Affiliations

¹ Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.
² Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer, Collegeville, PA, USA.
³ Pfizer Pharma GmbH, Berlin, Germany.
⁴ These authors contributed equally.

Abstract

In Germany, the proportion of community-acquired pneumonia due to Streptococcus pneumoniae rebounded to a near-pandemic level in the second half of 2021. Vaccination uptake against respiratory pathogens, including S. pneumoniae, should be strengthened. https://bit.ly/3JMlwFt.